So you’ve developed a great new specialty drug but will patients and providers utilize your therapy correctly? A great hub can help but implementing one is no easy task.
Justine Hughes, a vice president with Archbow Consulting, joins The IDI to explain where pharma and biotech hubs stumble -- and how they can succeed.
Follow Justine Hughes on LinkedIn.
Follow Valuate on LinkedIn.
Learn more about Valuate.
More episodes from "The IDI"



Don't miss an episode of “The IDI” and subscribe to it in the GetPodcast app.








